Alignment Healthcare, Inc. (ALHC)
Overview:
- Alignment Healthcare, Inc. is a tech-enabled Medicare advantage company based in Orange, California.
- The company operates a consumer-centric healthcare platform for seniors in the United States, providing customized healthcare designed to meet the needs of a diverse array of seniors through its Medicare advantage plans.
- Founded in 2013, Alignment Healthcare has 1,536 full-time employees and is in the healthcare sector.
- The company's website is alignmenthealthcare.com.
Financial Summary:
- Alignment Healthcare's fiscal year ended in 2022.
- The company's revenue for the last fiscal year was $1.82 billion, with a revenue growth of 28.6%.
- The net income to common shareholders was -$148 million, with a trailing EPS of -$0.79.
- The company's profit margins are -8.12% and the gross margins are 11.02%.
Stock Information:
- Ticker: ALHC
- Exchange: NMS
- Current Price: $5.02
- Previous Close: $4.95
- Market Cap: $948.67 million
- 52-Week Range: $4.46 – $9.20
- Average Volume: 898,332
- Shares Outstanding: 188.98 million
Company Officers:
- Mr. John E. Kao – Founder, President, CEO & Director
- Mr. Robert Thomas Freeman – Chief Financial Officer
- Ms. Dawn Christine Maroney – President of Health Markets & CEO of Health Plan
- Dr. Donald S. Furman M.B.A., M.D. – Co-Founder & Chief Clinical Officer
- Ms. Charlotte LeBlanc – Chief Accounting Officer and Senior Vice President
- Mr. Robert L. Scavo – Chief Information Officer
- Mr. Christopher J. Joyce – Chief Legal & Administrative Officer
- Ms. Amanda Root – Chief Communications Officer
- Mr. Andreas Wagner – Chief People Officer
- Dr. Hyong J. Kim M.D. – Chief Medical Officer
Prediction:
- The stock is currently trading at $5.02, with a 52-week range of $4.46 – $9.20.
- The target mean price for the stock is $8.10, with a high target price of $11.00 and a low target price of $4.50.
- The stock has a recommendation mean of 2.2, indicating a "buy" recommendation by analysts.
- The stock has a forward P/E ratio of -10.68, suggesting negative earnings in the future.
- The peg ratio is 0.23, indicating a low valuation compared to expected earnings growth.
Conclusion:
Alignment Healthcare, Inc. is a healthcare company focused on providing customized healthcare to seniors through its Medicare advantage plans. The company's financials show strong revenue growth but negative earnings. The stock is currently trading at $5.02 and has a target mean price of $8.10. Analysts recommend buying the stock, but investors should consider the negative earnings and evaluate the company's potential for future growth.
